|
|
 |
Agenda
Wednesday,
April 11, 2001
|
| 7:30-8:00
am |
Registration/Continental
breakfast
|
 |
|
| 8:00-8:10
am |
Introductions
|
 |
|
| 8:10-8:20
am |
NIDDK
Perspective
|
 |
|
| 8:20-8:30
am |
HCFA
Perspective
|
| |
|
| 8:30-9:10
am |
Session
I: Mechanisms of Efficacy, Solute Kinetics
|
| |
|
| 8:50-9:10
am |
Discussion
|
| |
|
| 9:10-10:20
am |
Session
II: Background on Issue, Current Results, Experience
|
| |
|
| 10:00-10:20
am |
Discussion
|
| |
|
| 10:40-12:00
pm |
Session
III: Trial Design Issues
|
| |
|
| 11:20-12:00
pm |
Discussion
|
| |
|
| 1:30-2:30
pm |
Session
IV: Industry Roundtable
|
| |
|
| 2:30-4:00
pm |
Economic
Issues
|
| |
|
| 3:10-4:00
pm |
Discussion
|
| |
|
| 5:00-8:00
pm |
Breakout
Sessions: Working Dinner at hotel
a.
Trial Design Short daily sessions
b. Trial Design Long nocturnal sessions
c. Economic Issues Payment and Outcomes
d. Epidemiological Monitoring
|
| |
|
| |
Thursday,
April 12, 2001
|
| 8:00-8:30
am |
Discussion:
Breakout Groups |
| |
|
| 8:30-10:30 |
Recommendations
from Breakout Groups |
| |
|
| 8:30-9:00 |
a.
Trial Design Short daily sessions |
| |
|
| 9:00-9:30 |
b.
Trial Design Long nocturnal sessions. |
| |
|
| 9:30-10:00 |
c.
Economic Issues Payment and Outcomes |
| |
|
| 10:00-10:30 |
d.
Epidemiological Monitoring |
| |
|
| 10:30-11:00 |
Discussion
and Wrap-Up |
| |
|
| 11:00
am |
Adjourn
|